Skip to main content

Table 4 Measurement of oxidation-modified LDL antibodies, oxidative status, and parameters of blood in patients with myocardial infarction on the 1st and 12th days of the disease

From: Multivessel coronary artery disease, free fatty acids, oxidized LDL and its antibody in myocardial infarction

Variables Control, n = 33 Group 1, ≥ 75% stenosis of a coronary artery, n = 135 Group 2, ≥ 75% stenosis 2 coronary, n = 115 Group 3, ≥ 75% stenosis of 3 or more coronary arteries, n = 150
1-th day 12-th day 1-th day 12-th day 1-th day 12-th day
Oxidized LDL, ng/mL 359.69 (324.56;389.23) 384.14 (349.52;412.1) 481.55 (411.25;533.21)b 409.13 (379.26;430.14)ac 605.23 (556.98;352.15)bc 717.16 (689.65;745.68)acd 1023.74 (956.21;1068.21)bcd
Oxidized LDL antibody, mU/mL 206.82 (189.63;225.32) 284.36 (251.23;312.23)a 395.72 (374.25;423.21)b 334.08 (316.59;354.12)ac 382.05 (369.24;399.96)bc 484.47 (459,82;509.51)acd 545.59 (521.32;574.25)bcd
Serum protein thiol, mcmol/L 515.1 (501.52;545.25) 646.42 (610.75;689.65)a 738.24 (698.23;769.6)b 735.84 (695.24;774.23)a 768.44 (726.24;789.65) 722.26 (692.12;761.15)a 753.34 (721.65;786.12)
Peroxide, mcmol/L 194.8 (189.32;208.45) 370.88 (345.26;396.21)a 451.05(423,89;478.21) 362.34 (326.25;386.25)a 408.85 (374.28;432.51) 391.00 (379.25;413.58)a 454.99 (423.11;489.25)
  1. Note: a - reliable differences in the parameters with the control group, (p ≤ 0.05).
  2. b - reliable difference parameters on day 1 and 12, (p ≤ 0.05).
  3. c - reliable difference between 1 and 2, groups 1 and 3, (p ≤ 0.05).
  4. d - reliable differences in the parameters between groups 2 and 3, (p ≤ 0.05)